Since hypoxia is known to enrich for cancer stem cells, we next studied the effect of inhibition of hypoxia on CD133+ cancer stem cell population, our results showed that downregulation of hypoxia and hypoxia mediated signaling decreased the CD133 expression level in pancreatic cancer cells. The gene discussed is PROM1; the disease is pancreatic neoplasm.